+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Blood Group Typing Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 200 Pages
  • September 2024
  • Region: Global
  • Expert Market Research
  • ID: 6015984
The global blood group typing market attained a value of nearly USD 2.4 billion in 2023. The market is estimated to grow at a CAGR of 9.1% during the period 2024-2032, reaching D 5.21 billion by 2032. This growth is driven by increasing demand for blood transfusions, advancements in blood typing technologies, and rising awareness about blood donation and safety, alongside supportive government initiatives.

Global Blood Group Typing Market Analysis

Blood group typing is a critical process in medical diagnostics and transfusion medicine, involving the identification of blood group antigens on red blood cells. Accurate blood group typing ensures donor and recipient blood compatibility, preventing adverse reactions during transfusions and organ transplants. The procedure typically involves serological tests, molecular techniques, and advanced assays to determine ABO and Rh blood groups, among others. With rising demand for blood transfusions, advancements in diagnostic technologies, and increased awareness about blood safety, the blood group typing market is witnessing significant growth, enhancing patient care and safety across healthcare settings.

Market Drivers

Technological Advancements: Continuous innovation in blood typing technology has significantly enhanced the accuracy and efficiency of blood group typing. These advancements are driving market growth as healthcare providers seek more reliable and faster solutions. Enhanced molecular techniques, such as PCR-based and microarray methods, offer precise results. Additionally, the development of automated systems is improving the speed and reliability of blood typing processes, ensuring better compatibility for transfusions and transplants. These technological improvements are making blood typing more accessible and dependable, broadening the market reach.

Government Initiatives: Governments worldwide are implementing policies and programs to promote blood donation and ensure the safety of blood transfusions. These initiatives significantly boost market demand by increasing awareness and accessibility of blood typing services. Public health campaigns and subsidies for blood typing equipment are supporting healthcare facilities in adopting advanced blood typing technologies, thereby enhancing the overall safety and reliability of blood transfusions.

Rising Prevalence of Chronic Diseases: The growing incidence of chronic diseases, such as cancer and anemia, which often require blood transfusions, is driving the demand for blood group typing. Accurate blood typing is crucial for managing these conditions and ensuring patient safety during transfusions. This rising prevalence underscores the importance of reliable blood typing in healthcare, thereby propelling market growth.

Increasing Blood Donations: The rise in voluntary blood donations is positively impacting the blood group typing market. Campaigns and awareness programs encouraging blood donation are leading to an increased need for blood typing services to ensure donor-recipient compatibility. The growing number of blood donors necessitates accurate and efficient blood typing, further driving market expansion.

Market Challenges

High Costs: The high cost of advanced blood typing instruments and reagents can limit accessibility, especially in low-income regions. This financial barrier is a significant challenge for the widespread adoption of advanced blood typing technologies. Efforts to reduce costs and improve affordability are essential to expanding market reach and ensuring that more healthcare facilities can offer reliable blood typing services.

Limited Availability of Trained Personnel: The lack of skilled professionals trained in advanced blood typing techniques can hinder market growth. Ensuring proper training and availability of qualified personnel is essential for the effective use of blood typing technologies. Investment in education and training programs is crucial to addressing this challenge and supporting the growth of the blood typing market.

Regulatory Hurdles: Stringent regulatory requirements for the approval and certification of blood typing products can delay market entry and increase development costs. These regulatory challenges can be significant obstacles for manufacturers aiming to introduce new technologies. Navigating these regulations effectively is essential for the timely and successful launch of innovative blood typing solutions.

Risk of Transfusion-Related Infections: Despite advancements, the risk of transfusion-related infections remains a challenge. Ensuring the safety and compatibility of blood transfusions through accurate blood typing is crucial to mitigating this risk. Continuous improvement in testing methods and adherence to stringent safety protocols are necessary to overcome this challenge and maintain trust in blood transfusion practices.

Future Opportunities

Emerging Markets: Expanding into emerging markets with improving healthcare infrastructure presents substantial growth opportunities. These regions offer untapped potential for increasing access to blood typing services and improving patient outcomes. Strategic investments and partnerships in these areas can drive market growth and enhance the availability of reliable blood typing technologies.

Integration with Advanced Diagnostic Tools: Incorporating advanced diagnostic tools, such as next-generation sequencing and AI-based analysis, can enhance the accuracy and efficiency of blood typing. These innovations can drive market growth by providing more precise and reliable results, facilitating better patient care and safety. The integration of these technologies is expected to revolutionize blood typing practices.

Development of Automated Systems: The development of automated blood typing systems can streamline processes and reduce human error. These systems can improve efficiency and accuracy, making blood typing more accessible and reliable. Automation in blood typing laboratories is expected to drive market growth by enhancing throughput and consistency in results.

Collaborations and Partnerships: Strategic partnerships between diagnostic companies and healthcare providers can drive market expansion. Collaborations can facilitate research, development, and distribution efforts, enhancing the availability and quality of blood typing services. Joint ventures and alliances are essential for leveraging expertise and resources to innovate and expand market offerings.

Market Trends

Adoption of Molecular Techniques: The adoption of molecular techniques, such as PCR and microarray, is revolutionizing blood group typing. These techniques offer higher accuracy and faster results, driving their popularity in clinical settings. The trend towards molecular diagnostics is enhancing the reliability of blood typing, supporting better patient outcomes and market growth.

Focus on Personalised Medicine: There is a growing trend towards personalized medicine, which includes precise blood typing to ensure compatibility in transfusions and transplants. This trend is driving the demand for advanced blood typing techniques. Personalized approaches in blood typing are expected to improve treatment outcomes and patient safety, further propelling the market growth.

Increased Investment in R&D: Investment in research and development for blood typing technologies is on the rise. Companies are dedicating significant resources to discovering new techniques and improving existing ones, fostering innovation in the market. Enhanced R&D efforts are expected to yield advanced blood typing solutions, driving future market growth.

Emphasis on Safety and Accuracy: Ensuring the safety and accuracy of blood transfusions is a top priority. Advancements in blood typing technologies and stringent regulatory standards are enhancing the reliability of blood typing services, supporting market growth. The emphasis on safety and accuracy is expected to continue driving innovation and adoption in the blood typing market.

Global Blood Group Typing Market Segmentation

Market Breakup by Offering

  • Consumables
  • Antisera Reagents
  • Anti-Human Globulin Reagents
  • Blood Bank Saline
  • Instruments
  • Services
The global blood group typing market is segmented by offering consumables, instruments, and services. Consumables include antisera reagents, anti-human globulin reagents, and blood bank saline, which are essential for routine blood typing procedures. Instruments such as automated blood typing systems enhance the efficiency and accuracy of blood typing. Services include laboratory testing and blood typing services offered by healthcare providers. Technological advancements and the increasing demand for accurate blood typing are driving the growth of these segments, ensuring reliable and efficient blood typing services.

Market Breakup by Test Type

  • Antibody Screening
  • HLA Typing
  • ABO Blood Tests
  • Cross-Matching Tests
  • Antigen Typing
The market is segmented by test type into antibody screening, HLA typing, ABO blood tests, cross-matching tests, and antigen typing. Each test type plays a crucial role in ensuring the compatibility and safety of blood transfusions and organ transplants. Antibody screening and cross-matching tests are essential for identifying potential incompatibilities, while HLA typing is critical for transplant compatibility. The growing need for precise and accurate blood typing tests is driving the demand for these segments.

Market Breakup by Technique

  • PCR-Based and Microarray Techniques
  • Assay-Based Techniques
  • Massively Parallel Sequencing
  • Others
The market is segmented by technique into PCR-based and microarray techniques, assay-based techniques, massively parallel sequencing, and others. PCR-based and microarray techniques offer high accuracy and rapid results, making them popular choices in clinical settings. Assay-based techniques and massively parallel sequencing are also gaining traction due to their efficiency and reliability. The continuous innovation and adoption of advanced techniques are driving market growth in these segments.

Market Breakup by End User

  • Hospital-based Laboratories
  • Independent Laboratories and Blood Banks
The market is segmented by end user into hospital-based laboratories independent laboratories and blood banks. Hospital-based laboratories are critical for providing immediate blood typing services for emergency and routine transfusions. Independent laboratories and blood banks play a vital role in supplying compatible blood products for various medical needs. The increasing demand for blood typing services in these end-user segments is driving market growth.

Market Breakup by Region

  • North America 
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
The global blood group typing market is segmented by region into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America and Europe lead the market due to advanced healthcare infrastructure and high awareness about blood donation and safety. The Asia Pacific region is emerging as a significant growth area, driven by improving healthcare access and increasing demand for blood transfusions. Latin America the Middle East and Africa are also poised for growth, supported by rising healthcare investments and awareness initiatives.

Global Blood Group Typing Market Competitive Landscape

The global blood group typing market features several key players actively shaping the competitive landscape. Notable companies include Grifols, S.A, Bio-Rad Laboratories, Inc., Immucor, Inc., Beckman Coulter, Inc., BAG Diagnostics GmbH, Quotient Limited, CareDx Inc, Agena Bioscience, Inc. (Mesa Laboratories, Inc.), DIAGAST, Illumina, Inc, and Thermo Fisher Scientific Inc. These companies engage in activities such as mergers and acquisitions, research initiatives, product introductions, and strategic partnerships to expand their market presence and capabilities. These activities drive innovation and growth within the blood group typing market, ensuring continuous improvement, and broadening service offerings.

Key Questions Answered in the Report

  • What is the expected CAGR of the global blood group typing market during the forecast period 2024-2032?
  • How are technological advancements driving the growth of the blood group typing market?
  • What role do government initiatives play in promoting blood donation and blood typing services?
  • How does the rising prevalence of chronic diseases impact the demand for blood group typing?
  • In what ways are increasing blood donations influencing the blood group typing market?
  • What are the main challenges associated with the high costs of advanced blood typing instruments and reagents?
  • How does the limited availability of trained personnel affect the growth of the blood group typing market?
  • What regulatory hurdles do manufacturers face in the blood group typing market?
  • How can emerging markets provide growth opportunities for the blood group typing market?
  • What are the benefits of integrating advanced diagnostic tools like next-generation sequencing and AI in blood typing?
  • How is the development of automated blood typing systems expected to drive market growth?
  • What are the key trends shaping the future of the blood group typing market, including the adoption of molecular techniques and the focus on personalized medicine?

Key Benefits for Stakeholders

  • The industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the global blood group typing market from 2017-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the global blood group typing market.
  • The study maps the leading, as well as the fastest-growing, regional markets, enabling stakeholders to identify key country-level markets within each region.
  • Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the global blood group typing industry and its attractiveness.
  • The competitive landscape section allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Blood Group Typing Market Overview
3.1 Global Blood Group Typing Market Historical Value (2017-2023)
3.2 Global Blood Group Typing Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Blood Group Typing Market Landscape*
5.1 Global Blood Group Typing: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Blood Group Typing: Product Landscape
5.2.1 Analysis by Offering
5.2.2 Analysis by Technique
5.2.3 Analysis by Test Type
6 Global Blood Group Typing Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Blood Group Typing Market Segmentation (2017-2032)
7.1 Global Blood Group Typing Market (2017-2032) by Offering
7.1.1 Market Overview
7.1.2 Consumables
7.1.2.1 Antisera Reagents
7.1.2.2 Anti-Human Globulin Reagents
7.1.2.3 Blood Bank Saline
7.1.3 Instruments
7.1.4 Services
7.2 Global Blood Group Typing Market (2017-2032) by Test Type
7.2.1 Market Overview
7.2.2 Antibody Screening
7.2.3 HLA Typing
7.2.4 ABO Blood Tests
7.2.5 Cross-Matching Tests
7.2.6 Antigen Typing
7.3 Global Blood Group Typing Market (2017-2032) by Technique
7.3.1 Market Overview
7.3.2 PCR-Based and Microarray Techniques
7.3.3 Assay-Based Techniques
7.3.4 Massively Parallel Sequencing
7.3.5 Others
7.4 Global Blood Group Typing Market (2017-2032) by End User
7.4.1 Market Overview
7.4.2 Hospital-based Laboratories
7.4.3 Independent Laboratories and Blood Banks
7.5 Global Blood Group Typing Market (2017-2032) by Region
7.5.1 Market Overview
7.5.2 North America
7.5.3 Europe
7.5.4 Asia Pacific
7.5.5 Latin America
7.5.6 Middle East and Africa
8 North America Blood Group Typing Market (2017-2032)
8.1 North America Blood Group Typing Market (2017-2032) by Offering
8.1.1 Market Overview
8.1.2 Consumables
8.1.2.1 Antisera Reagents
8.1.2.2 Anti-Human Globulin Reagents
8.1.2.3 Blood Bank Saline
8.1.3 Instruments
8.1.4 Services
8.2 North America Blood Group Typing Market (2017-2032) by Test Type
8.2.1 Market Overview
8.2.2 Antibody Screening
8.2.3 HLA Typing
8.2.4 ABO Blood Tests
8.2.5 Cross-Matching Tests
8.2.6 Antigen Typing
8.3 North America Blood Group Typing Market (2017-2032) by Technique
8.3.1 Market Overview
8.3.2 PCR-Based and Microarray Techniques
8.3.3 Assay-Based Techniques
8.3.4 Massively Parallel Sequencing
8.3.5 Others
8.4 North America Blood Group Typing Market (2017-2032) by End User
8.4.1 Market Overview
8.4.2 Hospital-based Laboratories
8.4.3 Independent Laboratories and Blood Banks
8.5 North America Blood Group Typing Market (2017-2032) by Country
8.5.1 United States of America
8.5.2 Canada
9 Europe Blood Group Typing Market (2017-2032)
9.1 Europe Blood Group Typing Market (2017-2032) by Offering
9.1.1 Market Overview
9.1.2 Consumables
9.1.2.1 Antisera Reagents
9.1.2.2 Anti-Human Globulin Reagents
9.1.2.3 Blood Bank Saline
9.1.3 Instruments
9.1.4 Services
9.2 Europe Blood Group Typing Market (2017-2032) by Test Type
9.2.1 Market Overview
9.2.2 Antibody Screening
9.2.3 HLA Typing
9.2.4 ABO Blood Tests
9.2.5 Cross-Matching Tests
9.2.6 Antigen Typing
9.3 Europe Blood Group Typing Market (2017-2032) by Technique
9.3.1 Market Overview
9.3.2 PCR-Based and Microarray Techniques
9.3.3 Assay-Based Techniques
9.3.4 Massively Parallel Sequencing
9.3.5 Others
9.4 Europe Blood Group Typing Market (2017-2032) by End User
9.4.1 Market Overview
9.4.2 Hospital-based Laboratories
9.4.3 Independent Laboratories and Blood Banks
9.5 Europe Blood Group Typing Market (2017-2032) by Country
9.5.1 United Kingdom
9.5.2 Germany
9.5.3 France
9.5.4 Italy
9.5.5 Others
10 Asia Pacific Blood Group Typing Market (2017-2032)
10.1 Asia Pacific Blood Group Typing Market (2017-2032) by Offering
10.1.1 Market Overview
10.1.2 Consumables
10.1.2.1 Antisera Reagents
10.1.2.2 Anti-Human Globulin Reagents
10.1.2.3 Blood Bank Saline
10.1.3 Instruments
10.1.4 Services
10.2 Asia Pacific Blood Group Typing Market (2017-2032) by Test Type
10.2.1 Market Overview
10.2.2 Antibody Screening
10.2.3 HLA Typing
10.2.4 ABO Blood Tests
10.2.5 Cross-Matching Tests
10.2.6 Antigen Typing
10.3 Asia Pacific Blood Group Typing Market (2017-2032) by Technique
10.3.1 Market Overview
10.3.2 PCR-Based and Microarray Techniques
10.3.3 Assay-Based Techniques
10.3.4 Massively Parallel Sequencing
10.3.5 Others
10.4 Asia Pacific Blood Group Typing Market (2017-2032) by End User
10.4.1 Market Overview
10.4.2 Hospital-based Laboratories
10.4.3 Independent Laboratories and Blood Banks
10.5 Asia Pacific Blood Group Typing Market (2017-2032) by Country
10.5.1 China
10.5.2 Japan
10.5.3 India
10.5.4 ASEAN
10.5.5 Australia
10.5.6 Others
11 Latin America Blood Group Typing Market (2017-2032)
11.1 Latin America Blood Group Typing Market (2017-2032) by Offering
11.1.1 Market Overview
11.1.2 Consumables
11.1.2.1 Antisera Reagents
11.1.2.2 Anti-Human Globulin Reagents
11.1.2.3 Blood Bank Saline
11.1.3 Instruments
11.1.4 Services
11.2 Latin America Blood Group Typing Market (2017-2032) by Test Type
11.2.1 Market Overview
11.2.2 Antibody Screening
11.2.3 HLA Typing
11.2.4 ABO Blood Tests
11.2.5 Cross-Matching Tests
11.2.6 Antigen Typing
11.3 Latin America Blood Group Typing Market (2017-2032) by Technique
11.3.1 Market Overview
11.3.2 PCR-Based and Microarray Techniques
11.3.3 Assay-Based Techniques
11.3.4 Massively Parallel Sequencing
11.3.5 Others
11.4 Latin America Blood Group Typing Market (2017-2032) by End User
11.4.1 Market Overview
11.4.2 Hospital-based Laboratories
11.4.3 Independent Laboratories and Blood Banks
11.5 Latin America Blood Group Typing Market (2017-2032) by Country
11.5.1 Brazil
11.5.2 Argentina
11.5.3 Mexico
11.5.4 Others
12 Middle East and Africa Blood Group Typing Market (2017-2032)
12.1 Middle East and Africa Blood Group Typing Market (2017-2032) by Offering
12.1.1 Market Overview
12.1.2 Consumables
12.1.2.1 Antisera Reagents
12.1.2.2 Anti-Human Globulin Reagents
12.1.2.3 Blood Bank Saline
12.1.3 Instruments
12.1.4 Services
12.2 Middle East and Africa Blood Group Typing Market (2017-2032) by Test Type
12.2.1 Market Overview
12.2.2 Antibody Screening
12.2.3 HLA Typing
12.2.4 ABO Blood Tests
12.2.5 Cross-Matching Tests
12.2.6 Antigen Typing
12.3 Middle East and Africa Blood Group Typing Market (2017-2032) by Technique
12.3.1 Market Overview
12.3.2 PCR-Based and Microarray Techniques
12.3.3 Assay-Based Techniques
12.3.4 Massively Parallel Sequencing
12.3.5 Others
12.4 Middle East and Africa Blood Group Typing Market (2017-2032) by End User
12.4.1 Market Overview
12.4.2 Hospital-based Laboratories
12.4.3 Independent Laboratories and Blood Banks
12.5 Middle East and Africa Blood Group Typing Market (2017-2032) by Country
12.5.1 Saudi Arabia
12.5.2 United Arab Emirates
12.5.3 Nigeria
12.5.4 South Africa
12.5.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Global
17.1.2 Market Share Analysis: North America
17.1.3 Market Share Analysis: Europe
17.1.4 Market Share Analysis: Asia Pacific
17.1.5 Market Share Analysis: Others
17.2 Grifols, S.A
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Company News and Developments
17.2.5 Certifications
17.3 Bio-Rad Laboratories, Inc .
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Company News and Developments
17.3.5 Certifications
17.4 Immucor, Inc
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Company News and Developments
17.4.5 Certifications
17.5 Beckman Coulter, Inc .
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Company News and Developments
17.5.5 Certifications
17.6 BAG Diagnostics GmbH
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Company News and Developments
17.6.5 Certifications
17.7 Quotient Limited
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Company News and Developments
17.7.5 Certifications
17.8 CareDx Inc
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Company News and Developments
17.8.5 Certifications
17.9 Agena Bioscience, Inc. (Mesa Laboratories, Inc .)
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Company News and Developments
17.9.5 Certifications
17.10 DIAGAST
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Company News and Developments
17.10.5 Certifications
17.11 Illumina, Inc
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Company News and Developments
17.11.5 Certifications
17.12 Thermo Fisher Scientific Inc .
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Company News and Developments
17.12.5 Certifications
18 Global Blood Group Typing Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)

Companies Mentioned

  • Grifols, S.A.
  • Bio-Rad Laboratories, Inc.
  • Immucor, Inc.
  • Beckman Coulter, Inc.
  • BAG Diagnostics GmbH

Methodology

Loading
LOADING...

Table Information